Cancel
Peter Bertinato
Director of Medicinal Chemistry
@
1910 Genetics
About Peter Bertinato
Peter Bertinato is a seasoned Director of Medicinal Chemistry with over 25 years of experience in drug discovery and development, and has contributed to the discovery of several drug candidates, including the FDA-approved SelentrolTM.
Known information
Peter Bertinato has built a distinguished career spanning more than 25 years in the field of medicinal chemistry, focusing on drug discovery and development. He has played a pivotal role in the discovery of numerous preclinical and clinical drug candidates, notably contributing to the development of SelentrolTM, an FDA-approved veterinary medicine. Bertinato has held the position of Director of Medicinal Chemistry at Reverie Labs, where he led significant projects in medicinal chemistry. Prior to this, he served in senior scientist roles at several prominent pharmaceutical companies, including Eisai, Epix, and Pfizer. Additionally, Bertinato has provided his expertise as a consultant to various small biotech firms and the Cystic Fibrosis Foundation, further enhancing his reputation in the pharmaceutical industry.
About 1910 Genetics
1910 Genetics, based in Cambridge, MA, integrates AI with proprietary data to advance drug discovery in neurological, autoimmune diseases, and cancer, aiming to make undruggable targets obsolete.
Report inaccurate information
